šĀ·1d agodiscovery
VYLOY (zolbetuximab) in combination with chemotherapy is NOW AVAILABLE and approved for first-line treatment of eligible* adult patients with gastric or gastroesophageal junction adenocarcinoma in India
Publisher
T
The Eastern Herald
Global
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalAt a glance
- Publisher
- The Eastern Herald
- Region
- Global
- Scope
- discovery
- Published
- August 1, 2026
- Language
- EN
In-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on news.google.com
Leave the platform to read the original full article on the publisher site.
Source: The Eastern Herald
Scope: discovery
Related coverage
More related coverage
UK Health Security Agency/3h ago
UKHSA updates heat health alerts across England
An amber heat-health alert has been issued for the East Midlands, East of England, South East and Lo...
news24online.com/4h ago
THIS āmad scientistā built Indiaās first pharmaceutical company, made major discoveries in Chemistry, donated entire fortune to charity, his name wasā¦
The Independent Uganda/5h ago
STUDY: HIV injectable drug offers pregnant, lactating mothers 100% protection
newsonair.gov.in/5h ago